From the Editor-in-Chief
"Of all the forms of inequality, injustice in health is the most shocking and inhuman.”
–Dr. Martin Luther King Jr.
by William G. Nelson, MD, PhD
The Evolution of Cancer | Breast Density Matters | More Options for Adolescents in Clinical Trials | Choosing a Cancer Center | The Cost of Prescriptions | Tackling Drug Resistance | Scientists Take a Stand | By The Numbers
Your Cancer Guide
Follow these tips for discussing your diagnosis and treatment plan with your kids.
by Hester Hill Schnipper
Caregiving With Confidence
Develop a system to avoid being overwhelmed by health care bills and information.
by Aimee Swartz
More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.
by Sue Rochman
A self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire.
by Jenny Song
Before undergoing surgery, cancer patients should look for experienced surgeons, get second opinions and ask about the risks and benefits.
by Stephen Ornes
Physicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.
by Kate Yandell
Inflammation Connection | Small Strides
Researcher Tom Marsilje is helping fellow colorectal cancer patients sort through clinical trials.
Assisting a co-worker with cancer, what you should ask your doctor, and dating and cancer.
Ann W. Calahan started Joe's House to help cancer patients and others find places to stay when they're being treated away from home.
by Cameron Walker
Karyn Marshall, James Gathright, Catherine Hargrove.
A proposed federal rule says that patients must be informed after mammograms if they have dense breasts.
by Carly Weeks
Drugs that target DNA repair enzymes may provide alternatives to long-term chemotherapy for some patients with pancreatic cancer.
Survivors and advocates display their posters alongside the work of thousands of cancer researchers.
by Kevin McLaughlin
Drug developers behind the six currently approved checkpoint inhibitors discuss the pros and cons of competition in the field.
A pair of studies demonstrated encouraging clinical outcomes with two different CAR T-cell therapies for patients with advanced solid tumors.
The U.S. Food and Drug Administration has for the first time approved an immunotherapeutic for breast cancer.
Researchers are studying how to treat EGFR-positive non-small cell lung cancer that has become resistant to tyrosine kinase inhibitors.
A Lesson in Service
donate to the AACR